Advertisement

Tumours and Hyperplasias of the Endocrine Pancreas

  • A. H. Cruickshank

Abstract

Although Neve, in 1891, described an adenoma that he had found by chance in the head of the pancreas, the microscopic appearances that he recorded do not allow the modern reader to identify that tumour as an adenoma of islet cells, and the first recognition of an adenoma of islet cells is attributed to Nicholls in 1902. In 1903 Fabozzi described the pathological findings in five cases of carcinoma of the pancreas in each of which he found, and illustrated, microscopic appearances that seemed to show that the tumours had originated from islet cells, but his paper included no clinical information that might have distinguished his cases from cases of carcinoma of the exocrine pancreas. Nicholls, who found a peasized nodule by accident on the anterior surface of the pancreas, attributed no clinical significance to the lesion, and although similar tumours were soon found by others, it was not until insulin had been discovered that the possibility that tumours of islet tissue might be hormonally active was realised. In 1927 Wilder et al. described a case in which the patient, who was himself a doctor, suggested that his symptoms resembled the effects produced by excess of insulin. He was found to have a cystic tumour in the tail of his pancreas with metastases in the liver and lymph nodes. Alcoholic extracts of the cancer tissue in the liver had an insulin-like action when they were injected into rabbits.

Keywords

Islet Cell Carcinoid Tumour Pancreatic Polypeptide Endocrine Pancreas Carcinoid Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ackerman LV, Rosai I (1974) Surgical pathology, 5th edn. CV, Mosby Co, St Louis, p 575Google Scholar
  2. Allison MC, Renfrew CC, Webb WJS, Chappell ME, Pounder RE (1985) Neuroendocrine islet cell tumour producing gastrin and ACTH in a patient with calcifying chronic pancreatitis. Gut 26:426–428PubMedCrossRefGoogle Scholar
  3. Alroy J, Baldwin D Jr, Maschgan ER (1980) Multiple beta cell neoplasms in a polar bear. Vet Pathol 17:331–337PubMedGoogle Scholar
  4. Berger M, Bordi C, Cüppers H-J, Berchtold P, Gries FA, Münterfering H, Sailor R, Zimmermann H, Orci L (1983) Functional and morphologic characterization of human insulinomas. Diabetes 32:921–931PubMedCrossRefGoogle Scholar
  5. Bickerstaff ER, Dodge OG, Gourevitch A, Hearn GW (1955) Adenomatosis of the islets of Langerhans. Br Med J II:997–1000CrossRefGoogle Scholar
  6. Bloodworth JMB, Greider MH (1982) The endocrine pancreas and diabetes mellitus. In: Bloodworth JMB Jr (ed) Endocrine pathology, 2nd edn. Williams and Wilkins, Baltimore, pp 556–721Google Scholar
  7. Bloom SR (1972) An enteroglucagon tumour. Gut 13:520–523PubMedCrossRefGoogle Scholar
  8. Bloom SR (1975) Glucagon. Br J Hosp Med 13:150–158Google Scholar
  9. Bloom SR, Christofides ND, Delamarter J, Buell G, Kawashima E, Polak JM (1983) Diarrhoea in vipoma patients associated with cosecretion of a second active peptide (peptide histidine isoleucine) explained by single coding gene. Lancet II:1163–1165CrossRefGoogle Scholar
  10. Bloom SP, Polak JM, Pearse AGE (1973) Vasoactive intestinal peptide and watery-diarrhoea syndrome. Lancet II: 14–16CrossRefGoogle Scholar
  11. Boden G, Owen OE (1977) Familial hyperglucagonemia—an autosomal dominant disorder. N Engl J Med 296:534–538PubMedCrossRefGoogle Scholar
  12. Bordi C, Togni R, Baetens D, Ravazzola D, Malaisse-Lagae F, Orci L (1978) Human islet cell tumor storing pancreatic polypeptide: A light and electron microscopic study. J Clin Endocrinol Metab 46:215–219PubMedCrossRefGoogle Scholar
  13. Brown CH, Neville WE, Hazard JB (1950) Islet cell adenoma without hypoglycaemia causing duodenal obstruction. Surgery 27:616–620Google Scholar
  14. Campbell ACP (1959) The pathological relationships of 5-hydroxytryptamine. In: Collins DH (ed) Modem trends in pathology. Butterworth, London, pp 231–247Google Scholar
  15. Cantor AM, Rigby CC, Beck PR, Mangion D (1982) Neurofibromatosis, phaeochromocytoma, and somatostatinoma. Br Med J IV: 1618–1619CrossRefGoogle Scholar
  16. Cardell BS (1953) Hypertrophy and hyperplasia of the pancreatic islets in new-bom infants. J Pathol Bacteriol 66:335–346PubMedCrossRefGoogle Scholar
  17. Cohen C, Budgeon LR (1982) Commercial immunoperoxidase kits in the study of 13 pancreatic islet cell tumors. Am J Clin Pathol 78:364–366PubMedGoogle Scholar
  18. Colin-Jones DG, Copping RML, Gibbs DD, Sharr MM (1969) Malignant Zollinger-Ellison ssmdrome with gastrin-containing skin metastases. Lancet 1:492–494PubMedCrossRefGoogle Scholar
  19. Creutzfeldt W (1977) Endocrine tumors of the pancreas. In: Volk BW, Wellmann KF (eds) The diabetic pancreas. Baillière Tindall, London, pp 551–590Google Scholar
  20. Creutzfeldt W (1980) Endocrine tumors of the pancreas: Clinical, chemical and morphological findings. In: Fitzgerald PJ, Morrison AB (eds) The pancreas. Williams and Wilkins, Baltimore, pp 208–230Google Scholar
  21. Croisier J-C, Azerad E, Lubetzki J (1971) L’adénomatose polyendocrinienne (sjnidrome de Wermer). A propos d’une observation personnelle. Revue de la litérature. Semaine des Hôpitaux de Paris 47:494–525PubMedGoogle Scholar
  22. Croughs RJM, Hulsmans HAM, Israël DE, Hackeng WHL, Schopman W (1972) Glucagonoma as part of the polyglandular adenoma syndrome. Am J Med 52:690–698PubMedCrossRefGoogle Scholar
  23. Cubilla AL, Hajdu SI (1975) Islet cell carcinoma of the pancreas. Arch Pathol 99:204–207PubMedGoogle Scholar
  24. D’Arcangues CM, Awoke S, Lawrence GD (1984) Metastatic insulinoma with long survival and glucagonoma syndrome. Ann Intern Med 100:233–235PubMedGoogle Scholar
  25. Duff GL, Murray EGD (1942) The pathology of islet cell tumors of the pancreas. Am J Med Sci 203:437–451CrossRefGoogle Scholar
  26. Ellison EW, Wilson SD (1964) The Zollinger-Ellison syndrome: Reappraisal and evaluation of 260 registered cases. Ann Surg 160:512–528PubMedCrossRefGoogle Scholar
  27. Fabozzi S (1903) Ueber die histogenese des primären Krebses des Pankreas. Beitr Path Anat Allg Path 34:199–214Google Scholar
  28. Feldman EC (1983) Diseases of the endocrine pancreas. In: Ettinger SJ (ed) Textbook of veterinary internal medicine. Diseases of the dog and cat. 2nd edn. WB Saunders, Philadelphia, London, pp 1644–1645Google Scholar
  29. Friesen SR (1967) Effect of total gastrectomy on the Zollinger-Ellison tumor: Observations by second-look procedures. Surgery 62:609–613PubMedGoogle Scholar
  30. Galmiche JP, Colin R, Dubois PM, Chayvialle JA, Descos F, Paulin C, Geffroy Y (1978) Calcitonin secretion by a pancreatic somatostatinoma. N Engl J Med 299:1252PubMedGoogle Scholar
  31. Gampa G, Gargantini L, Grigolato PG, Chiumello G (1976) Hypoglycemia of infancy caused by beta cell nesidioblastosis. Am J Dis Child 128:226–231Google Scholar
  32. Ganda OP, Weir GC, Soeldner JS, Legg MA, Chick WL, Patel YC, Ebeid AM, Gabbay KH, Reichlin S (1977) “Somatostatinoma”: A somatostatin-containing tumor of the endocrine pancreas. N Engl J Med 296:963–967PubMedCrossRefGoogle Scholar
  33. Garland H (1957) Pancreatic islet adenomatosis with hypoglycaemic episodes. Br Med J 11:969–971CrossRefGoogle Scholar
  34. Gelston AL, Delisle M-B, Patel YC (1982) Multiple endocrine adenomatosis type 1. Occurrence in an octogenarian with high levels of circulating pancreatic polypeptide, J Am Med Assoc 247:665–666CrossRefGoogle Scholar
  35. Gersell DJ, Gingerich RL, Greider MH (1979) Regional distribution and concentration of pancreatic polypeptide in the human and canine panceas. Diabetes 28:11–15PubMedCrossRefGoogle Scholar
  36. Ghosh L, Huvos AG, Miké V (1973) The pancreatic islets in chondrosarcoma. Am J Pathol 71:23–32PubMedGoogle Scholar
  37. Goodman ZD, Albores-Saavedra J, Lundblad DM (1984) Somatostatinoma of the cystic duct. Cancer 53:498–502PubMedCrossRefGoogle Scholar
  38. Goudswaard WB, Houthoff HJ, Koudstaal J, Bosman FT, Zwierstra RP (1984) Nesidioblastosis and islet cell hyperplasia of the pancreas—a secondary phenomenon—not a disease entity. J Pathol 143:301Google Scholar
  39. Gould VE, Memoll VA, Dardi LE, Gould NS (1983) Nesidiodysplasia and nesidioblastosis of infancy: Structural and functional correlations with the syndrome of hyperinsulinemic hypoglycemia. Pediatr Pathol 1:7–31PubMedCrossRefGoogle Scholar
  40. Grahame-Smith DG (1972) The carcinoid syndrome. Heinemann, LondonGoogle Scholar
  41. Gregory RA, Tracy HJ, French JM, Sircus W (1960) Extraction of a gastrin-like substance from a pancreatic tumour in a case of Zollinger-Ellison syndrome. Lancet 1:1045–1048PubMedCrossRefGoogle Scholar
  42. Gregory RA, Grossmann MI, Tracy HJ, Bentley PH (1967) Nature of the secretagogue in Zollinger-Ellison tumours. Lancet II: 543–544CrossRefGoogle Scholar
  43. Griffiths DER, Williams GT, Williams ED (1983) Multiple endocrine neoplasia associated with von Recklinghausen’s disease. Br Med J IV:1341–1343CrossRefGoogle Scholar
  44. Grotting JC, Kassel S, Dehner LP (1979) Nesidioblastosis and congenital neuroblastoma: A histologic and immunocytochemical study of a new complex neurocrystopathy. Arch Pathol Lab Med 103:642–646PubMedGoogle Scholar
  45. Gutniak M, Rosenquist U, Grimelius L, Lundberg IM, Hökfelt T, Rökaeus A, Rosell S, Lundquist G, Fahrenkrug J, Sundblad R, Gutiiiak E (1980) Report on a patient with watery diarrhoea syndrome caused by a pancreatic tumour containing neurotensin, enkephalin, and calcitonin. Acta Med Scand 208:95–100PubMedCrossRefGoogle Scholar
  46. Happé RP, van der Gaag I, Lamens CBHW, van Toorenburg J, Rehfeld JF, Larsson L-I (1980) Zollinger-Ellison syndrome in three dogs. Vet Pathol 17:178–186Google Scholar
  47. Hart WR, Hinerman DL (1965) Hyperplasia of pancreatic islets associated with extrapancreatic lymphoma and sarcoma. Metabolism 14:1158–1168PubMedCrossRefGoogle Scholar
  48. Heitz PU (1984) Pancreatic endocrine tumours. In: Klöppel G, Heitz PU (eds) Pancreatic pathology. Churchill Livingstone, Edinburgh, London, pp 206–232Google Scholar
  49. Heitz PU, Klöppel G, Häckl WH, Polak JM, Pearse AGE (1977) The pathologic basis of persistent hyperinsulinemic hypoglycemia in infants. Diabetes 26:632–642PubMedCrossRefGoogle Scholar
  50. Heitz PU, Kasper M, Polak JM, Klöppel G (1982) Pancreatic endocrine tumors: Immunocytochemical analysis of 125 tumors. Hum Pathol 13:263–271PubMedCrossRefGoogle Scholar
  51. Heitz PU, Kasper M, Klöppel G, Polak IM, Vaitiikaitis JL (1983) Glycoprotein-hormone alpha-chain production by pancreatic endocrine tumors: A specific marker for malignancy. Cancer 51:277–282PubMedCrossRefGoogle Scholar
  52. Hull MT, Warfel KA, Muller J, Higgins JH (1979) Familial islet cell tumors in von Hippel-Lindau’s disease. Cancer 44:1523–1526PubMedCrossRefGoogle Scholar
  53. Jensen SL, Christiansen LA, Oxholm A-M, Hoist JJ (1984) Duodenal somatostatinoma. Br J Surg 71:159PubMedCrossRefGoogle Scholar
  54. Jones BR, Nicholls MR, Badman R (1976) Peptic ulceration in a dog associated with an islet cell carcinoma of the pancreas and an elevated plasma gastrin level. J Small Animal Pract 17:593–598CrossRefGoogle Scholar
  55. Kane MG, O’Dorisio TM, Krejs GJ (1983) Production of secretory diarrhea by intravenous infusion of vasoactive intestinal polypeptide. N Engl J Med 309:1482–1485PubMedCrossRefGoogle Scholar
  56. Kaneko H, Yanaihara N, Ito S, Kusumoto Y, Figita T, Ishikawa S, Sumida T, Sekiya M (1979) Somatostatinoma of the duodenum. Cancer 44:2273–2279PubMedCrossRefGoogle Scholar
  57. Karnauchow PN (1982) Nesidioblastosis in adults without insular hyperfunction. Am J Clin Pathol 78:511–513PubMedGoogle Scholar
  58. Kimball CP, Murlin JR (1923–1924) Aqueous extracts of pancreas. Some precipitation reactions of insulin. J Biol Chem 58:337–346Google Scholar
  59. Klöppel G, Heitz PU (1984) Persistent hyperinsulinaemic hypoglycaemia in infancy. In: Klöppel G, Heitz PU (eds) Pancreatic pathology. Churchill Livingstone, London, pp 193–205Google Scholar
  60. Kovacs K, Horvath E, Ilse RG, Use D (1976) Spontaneous pancreatic beta cell tumor in the rat. Vet Pathol 13:286–294PubMedGoogle Scholar
  61. Kovacs K, Horvath E, Ezrin C, Sepp H, Elkan I (1977) Immunoreactive somatostatin in pancreatic islet-cell carcinoma accompanied by ectopic ACTH syndrome. Lancet I: 1365–1366CrossRefGoogle Scholar
  62. Krejs GJ (1980) Effect of VIP inftision on water and ion transport in the human large intestine. Gastroenterology 78:1200Google Scholar
  63. Krejs GJ, Orci L, Conlon JM, Ravazzola M, Davis GR, Raskin P, Collins SM, McCarthy DM, Baetens D, Rubenstein A, Aldor TAM, Unger RH (1979) Somatostatinoma syndrome: Biochemical morphologic and clinical features. N Engl J Med 301:285–292PubMedCrossRefGoogle Scholar
  64. Krejs GJ, Fordtran JS, Bloom SR, Fahrenkrug J, Schaffalitzky de Muckadell OB, Fischer JE, Humphrey CS, O’Dorisio TM, Said SI, Walsh JH, Shulkes AA (1980) Effect of VIP infusion on the water and ion transport in the human jejunum. Gastroenterology 78:722–727PubMedGoogle Scholar
  65. Laidlaw GF (1938) Nesidioblastoma, the islet cell tumor of the pancreas. Am J Pathol 14:125–134PubMedGoogle Scholar
  66. Larsson L-I, Shwartz T, Lundquist G, Chance RE, Sundler F, Rehfeld JF, Grimelius L, Fahrenkrug J, Schaffalitzky de Muckadell O, Moon N (1976) Occurrence of human pancreatic polypeptide in pancreatic endocrine tumors. Possible implication in the watery diarrhea syndrome. Am J Pathol 85:675–684PubMedGoogle Scholar
  67. Larsson L-I, Hirsch MA, Hoist JJ, Ingemansson S, Kühl C, Jensen SL, Lundquist G, Rehfeld JF, Schwartz TW (1977) Pancreatic somatostatinoma. Clinical features and physiological implications. Lancet 1:666–668PubMedCrossRefGoogle Scholar
  68. Ljungberg O, Järnerot G, Rolny P, Wickbom G (1981) Human pancreatic polypeptide (HPP) immunoreactivity in an infiltrating endocrine tumour of the papilla of vater with unusual morphology. Virchows Arch A 392:119–126Google Scholar
  69. Long RG, Bryant MG, Mitchell SJ, Adrian TE, Polak JM, Bloom SR (1981) Clinicopathological study of pancreatic and ganglioneuroblastoma tumours secreting vasoactive intestinal polypeptide (vipomas). Br Med J 11:1767–1771CrossRefGoogle Scholar
  70. Lopez-Kruger R, Dockerty MB (1947) Tumors of the islets of Langerhans. Surg Gynecol Obstet 85:495–511PubMedGoogle Scholar
  71. McGuigan JE, Trudeau WL (1968) Immunochemical measurement of elevated levels of gastrin in the serum of patients with pancreatic tumors of the Zollinger-Ellison variety. N Engl J Med 278:1308–1313PubMedCrossRefGoogle Scholar
  72. Malagelada JR, Edis AJ, Adson MA, van Heerden JA, Go VLW (1983) Medical and surgical options in the management of patients with gastrinoma. Gastroenterology 84:1524–1532PubMedGoogle Scholar
  73. Mallinson CN, Bloom SR, Warin AP, Salmon PR, Cox B (1974) A glucagonoma syndrome. Lancet II: 1–5CrossRefGoogle Scholar
  74. Marks C (1979) Carcinoid tumors: A clinicopathologic study. GK Halland, Boston, MassachusettsGoogle Scholar
  75. Marshall AHE, Sloper JC (1954) Pluriglandular adenomatosis of the pituitary, parathyroid and pancreatic islet cells associated with lipomatosis. J Pathol Bact 68:225–229CrossRefGoogle Scholar
  76. Modlin JM, Bloom SR, Mitchell SJ (1978) Experimental evidence of vasoactive intestinal peptide as the cause of the watery diarrhea syndrome. Gastroenterology 75:1051–1054PubMedGoogle Scholar
  77. Moldawer PM, Nardi GL, Raker JW (1954) Concomitance of multiple adenomas of the parathyroids and pancreatic islets with tumor of the pituitary: A syndrome with familial incidence. Am J Med Sci 228:190–206PubMedCrossRefGoogle Scholar
  78. Morrison AB (1980) Islet cell tumors and the diarrheogenic syndrome. In: Fitzgerald PJ, Morrison AB (eds) The pancreas. Williams and Wilkins, Baltimore, pp 185–207Google Scholar
  79. Neve ET (1891) On the morbid anatomy of the pancreas. Lancet II:659–661CrossRefGoogle Scholar
  80. Nicholls AG (1902) Simple adenoma of the pancreas arising from an island of Langerhans. J Med Res 8:385–395PubMedGoogle Scholar
  81. Norbin A, Berg M, Ericsson M, Ingemansson S, Olsson E, Sundler F (1984) Pancreatic polypeptide-producing tumors. Report on two cases. Cancer 53:2688–2691CrossRefGoogle Scholar
  82. Ohneda A, Otsuki M, Fugiya H, Yaginuma N, Kokubo T, Ohtani H (1979) A malignant insulinoma transformed into a glucagonoma syndrome. Diabetes 28:962–969PubMedGoogle Scholar
  83. O’Leary JL, Womack N (1934) Histology of adenoma of the islets of Langerhans. Arch Pathol 17:291–310Google Scholar
  84. Pagliara AS, Karl IE, Haymond M, Kipnis DM (1973) Hypoglycemia in infancy and childhood. Part 1. J Pediatr 82:365–379PubMedCrossRefGoogle Scholar
  85. Pearse AGE (1984) Islet development and the APUD concept. In: Klöppel G, Heitz PU (eds) Pancreatic pathology. Churchill Livingstone, London, p 127Google Scholar
  86. Pearse AGE, Polak JM, Heath CM (1974) Polypeptide hormone production by “carcinoid” apudomas and their relevant cytochemistry. Virchows Arch B 16:95–109Google Scholar
  87. Peart WS, Porter KA, Robertson JIS, Sandler M, Baldock E (1963) Carcinoid syndrome due to pancreatic-duct neoplasm secreting 5-hydroxytryptophan and 5-hydroxytryptamine. Lancet 1:239–242PubMedCrossRefGoogle Scholar
  88. Pipeleers D, Somers G, Gepts W, de Nutte N, de Vroede M (1979) Plasma pancreatic hormone levels in a case of somatostatinoma: Diagnostic and therapeutic implications. J Clin Endocrinol Metab 49:572–579PubMedCrossRefGoogle Scholar
  89. Polak JM, Wigglesworth JS (1976) Islet-cell hyperplasia and sudden infant death. Lancet II: 570–571CrossRefGoogle Scholar
  90. Polak JM, Stagg B, Pearse AGE (1972) Two types of Zollinger-Ellison syndrome: Immunofluorescent, cytochemical and ultrastructural studies of the antral and pancreatic gastrin cells in different clinical states. Gut 13:501–512PubMedCrossRefGoogle Scholar
  91. Polak JM, Bloom SR, Adrian TE, Heitz PU, Bryant MG, Pearse AGE (1976) Pancreatic polypeptide in insulinomas, gastrinomas, vipomas, and glucagonomas. Lancet 1:328–330PubMedCrossRefGoogle Scholar
  92. Ponsky JL, Hoffman M, Rhodes RS (1979) Arteriovenous fistula and portal hypertension secondary to islet cell tumor of the pancreas. Surgery 85:408–411PubMedGoogle Scholar
  93. Potter EL, Seckel HPG, Stryker WA (1941) Hypertrophy and hyperplasia of the islets of Langerhans of the fetus and the newborn infant. Arch Pathol 31:467–482Google Scholar
  94. Probst A, Lötz M, Heitz P (1978) Von Hippel-Lindau’s disease, syringomyelia and multiple endocrine tumors: A complex neuroendocrinopathy. Virchows Arch A 378:265–272Google Scholar
  95. Ravazzola M, Orci L (1980) Glucagon and glicentin immunoreactivity are topologically segregated in the alpha granule of the human pancreatic A cell. Nature 284:66–67PubMedCrossRefGoogle Scholar
  96. Rayman G, Santo M, Salomon F, Almog S, Paradinas FJ, Pinkhas J, Reynolds KW, Wise PH (1984) Hyperinsulinaemic hypoglycaemia due to chlorpropamide-induced nesidioblastosis. J Clin Pathol 37:651–654PubMedCrossRefGoogle Scholar
  97. Sandler M, Karim SMM, Williams ED (1968) Prostaglandins in amine-peptide-secreting tumours. Lancet 11:1053–1055CrossRefGoogle Scholar
  98. Shwartz SS, Rich BH, Lucky AW, Straus FH, Gonen B, Wolfsdorf J, Thorp FW, Burrington JD, Madden JD, Rubenstein AH, Rosenfield RL (1979) Familial nesidioblastosis: Severe neonatal hypoglycemia in two families. Pediatrics 95:44–53CrossRefGoogle Scholar
  99. Sipple JH (1961) The association of pheochromocytoma with carcinoma of the thyroid gland. Am J Med 31:163–166CrossRefGoogle Scholar
  100. Solt J, Kadas I, Polak JM, Nemeth A, Bloom SR, Rauth J, Horvath L (1984) A pancreatic-polypeptide-producing tumor of the stomach. Cancer 54:1101–1104PubMedCrossRefGoogle Scholar
  101. Somers G, Pipeleers-Marichal M, Gepts W, Pipeleers D (1983) A case of duodenal somatostatinoma: Diagnostic usefulness of calcium-pentagastrin test. Gastroenterology 85:1192–1198PubMedGoogle Scholar
  102. Spencer H (1955) Pancreatic islet-cell adenomata. J Pathol Bacteriol 69:259–267PubMedCrossRefGoogle Scholar
  103. Stefanini P, Carboni M, Patrassi N, Basoli A (1974) Beta-islet cell tumors of the pancreas: Results of a study on 1,067 cases. Surgery 75:597–609PubMedGoogle Scholar
  104. Steiner AL, Goodman AD, Powers SR (1968) A study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing’s disease: Multiple endocrine neoplasia type 2. Medicine 47:371–409PubMedCrossRefGoogle Scholar
  105. Straus E, Johnson GF, Yallow RS (1977) Canine Zollinger-Ellison syndrome. Gastroenterology 72:380–381PubMedGoogle Scholar
  106. Thompson NW, Ekhauser FE, Vinik AI, Uoyd RV, Fiddian-Green RG, Strodel WE (1984) Cystic neuroendocrine neoplasms of the pancreas and liver. Ann Surg 199:158–164PubMedCrossRefGoogle Scholar
  107. Tragi K-H, Mayr WR (1977) Familial islet-ceU adenomatosis. Lancet 11:426–428CrossRefGoogle Scholar
  108. Unger RH, Bochner J (1964) Identification of insulin and glucagon in a bronchogenic metastasis. J Clin Endocrinol Metab 24:823–831PubMedCrossRefGoogle Scholar
  109. Vance JE, Stoll RW, Kitabchi AE, Buchanan KD, Hollander D, Williams RH (1972) Familial nesidioblastosis as the predominant manifestation of multiple endocrine adenomatosis. Am J Med 52:211–227PubMedCrossRefGoogle Scholar
  110. van der SluysVeer J, Choufoer JC, Querido A, van der Heul RO, Hollander CF, van Ryssel TG (1964) Metastasising islet-cell tumour of the pancreas associated with hypoglycaemia and carcinoid syndrome. Lancet 1:1416–1419Google Scholar
  111. Verbov I (1981) Necrolytic migratory erythema associated with an islet cell tumour of the pancreas. Dermatologica 163:189–194PubMedCrossRefGoogle Scholar
  112. Verner JV, Morrison AB (1958) Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med 25:374–380PubMedCrossRefGoogle Scholar
  113. Warner TFCS, Seo IS, Madura JA, Polak JM, Pearse AGE (1980) Pancreatic-polypeptide-producing apudoma of the liver. Cancer 46:1146–1151PubMedCrossRefGoogle Scholar
  114. Warren S (1926) Adenomas of the islands of Langerhans. Am J Pathol 2:335–340PubMedGoogle Scholar
  115. Weichert R, Reed R, Creech O Jr (1967) Carcinoid-islet tumors of the duodenum. Ann Surg 165:660–669PubMedCrossRefGoogle Scholar
  116. Wells CA, Taylor SM, Cuello CA (1985) Argentaffin and argyrophil reactions and serotonin content of endocrine tumours. J Clin Pathol 38:49–53PubMedCrossRefGoogle Scholar
  117. Wermer P (1954) Genetic aspects of adenomatosis of endocrine glands. Am J Med 16:363–371PubMedCrossRefGoogle Scholar
  118. Wermer P (1963) Endocrine adenomatosis and peptic ulcer in a large kindred. Inherited multiple hormone-producing tumors and mosaic pleiotropism in man. Am J Med 35:205–212PubMedCrossRefGoogle Scholar
  119. Wermer P (1974) Multiple endocrine adenomatosis: Multiple hormone-producing tumours, a familial syndrome. In: Clinics in gastroenterology. Endocrine-secreting tumours of the G-I tiract, vol 3 (Sept. 1974). WB Saunders, London, Philadelphia, pp 671–684Google Scholar
  120. Wilder RM, Allan FN, Power MH, Robertson HE (1927) Carcinoma of the islands of the pancreas. Hyperinsulinism and hypoglycemia. J Am Med Assoc 89:348–355CrossRefGoogle Scholar
  121. Williams ED, Sandler M (1963) The classification of carcinoid timiours. Lancet 11:238–239CrossRefGoogle Scholar
  122. Zollinger RM, Ellison EH (1955) Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann Surg 142:709–728PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • A. H. Cruickshank
    • 1
  1. 1.LiverpoolUK

Personalised recommendations